Residual public repertoires to self

Journal of Neuroimmunology

Volumn 107, Issue 2, 2000, Pages 233-239

  Wilson, Stephen S ^a   Van Den Elzen, Peter ^a   Maverakis, Emanual ^a   Beech, Jonathan T ^a   Braciak, Todd A ^a   Kumar, Vipin ^a   Sercarz, Eli E ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Anergy; Deletion; EAE; Neonatal tolerance; T cell repertoire; T(H)1; T(H)2

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; IMMUNOGLOBULIN G; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CLONE; CONFERENCE PAPER; GENE; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MULTIPLE SCLEROSIS; NEUROIMMUNOMODULATION; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 0034710343     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00218-6     Document Type: Conference Paper

References (33)

1. Acha-Orbea H., Mitchell D.J., Timmermann L., Wraith D.C., Tausch G.S., Waldor M.K., Zamvil S.S., McDevitt H.O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:(2):1988;263-273.
2. Benichou G., Takizawa P.A., Ho P.T., Killion C.C., Olson C.A., McMillan M., Sercarz E.E. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J. Exp. Med. 172:(5):1990;1341-1346.
3. Bousso P., Casrouge A., Altman J.D., Haury M., Kanellopoulos J., Abastado J.P., Kourilsky P. Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. Immunity. 9:(2):1998;169-178.
4. Castellino F., Zappacosta F., Coligan J.E., Germain R.N. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J. Immunol. 161:(8):1998;4048-4057.
5. Cibotti R., Cabaniols J.P., Pannetier C., Delarbre C., Vergnon I., Kanellopoulos J.M., Kourilsky P. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:(3):1994;861-872.
6. Deng H., Apple R., Clare-Salzler M., Trembleau S., Mathis D., Adorini L., Sercarz E. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:(5):1993;1675-1680.
7. Elias D., Tikochinski Y., Frankel G., Cohen I.R. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide. Int. Immunol. 11:(6):1999;957-966.
8. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice [see comments]. Science. 271:(5256):1996;1728-1730.
9. Gammon G., Dunn K., Shastri N., Oki A., Wilbur S., Sercarz E.E. Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation. Nature. 319:(6052):1986;413-415.
10. Gammon G., Sercarz E. How some T cells escape tolerance induction. Nature. 342:(6246):1989;183-185.
11. Hafler D.A., Saadeh M.G., Kuchroo V.K., Milford E., Steinman L. TCR usage in human and experimental demyelinating disease. Immunol. Today. 17:(4):1996;152-159.
12. Harrington C.J., Paez A., Hunkapiller T., Mannikko V., Brabb T., Ahearn M., Beeson C., Goverman J. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity. 8:(5):1998;571-580.
13. Hong J., Zang Y.C., Tejada-Simon M.V., Kozovska M., Li S., Singh R.A., Yang D., Rivera V.M., Killian J.K., Zhang J.Z. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J. Immunol. 163:(6):1999;3530-3538.
14. Kumar V., Sercarz E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J. Immunol. 161:(12):1998;6585-6591.
15. Kumar V., Sercarz E.E. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:(3):1993;909-916.
16. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:(6382):1992;155-157.
17. Lohse A.W., Spahn T.W., Wolfel T., Herkel J., Cohen I.R., Meyer zum Buschenfelde K.H. Induction of the anti-ergotypic response. Int. Immunol. 5:(5):1993;533-539.
18. Maverakis, E., Beech, J.T., Wilson, S.S., Quinn, A., Pedersen, B., Sercarz, E.E., 2000. T cell receptor CDR3-length analysis reveals the absence of a characteristic public T cell repertoire in neonatal tolerance: the response in the tolerant mouse within the residual repertoire is quantitatively similar but qualitatively different. J. Exp. Med. (in press).
19. Moudgil K., Southwood S., Ametani A., Kim K., Sette A., Sercarz E. The self-directed T cell repertoire against mouse lysozyme reflects the influence of the hierarchy of its own determinants and can be engaged by a foreign lysozyme. J. Immunol. 163:(8):1999;4232-4237.
20. Musette P., Bequet D., Delarbre C., Gachelin G., Kourilsky P., Dormont D. Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients. Proc. Natl. Acad. Sci. USA. 93:(22):1996;12461-12466.
21. Nanda N.K., Apple R., Sercarz E. Limitations in plasticity of the T-cell receptor repertoire. Proc. Natl. Acad. Sci. USA. 88:(21):1991;9503-9507.
22. Oksenberg J.R., Panzara M.A., Begovich A.B., Mitchell D., Erlich H.A., Murray R.S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C.C., et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:(6415):1993;68-70.
23. Pannetier C., Cochet M., Darche S., Casrouge A., Zoller M., Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA. 90:(9):1993;4319-4323.
24. Sarzotti M., Robbins D.S., Hoffman P.M. Induction of protective CTL responses in newborn mice by a murine retrovirus [see comments]. Science. 271:(5256):1996;1726-1728.
25. Sercarz E.E., Araneo B., Benjamin C.D., Harvey M., Metzger D., Miller A., Wicker L., Yowell R. The design of regulatory circuitry: predominant idiotypy and the idea of regulatory parsimony. Ann. N.Y. Acad. Sci. 418:1983;198-205.
26. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:1993;729-766.
27. Sourdive D.J., Murali-Krishna K., Altman J.D., Zajac A.J., Whitmire J.K., Pannetier C., Kourilsky P., Evavold B., Sette A., Ahmed R. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:(1):1998;71-82.
28. Targoni O.S., Lehmann P.V. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:(12):1998;2055-2063.
29. Tuohy V.K., Yu M., Yin L., Kawczak J.A., Johnson J.M., Mathisen P.M., Weinstock-Guttman B., Kinkel R.P. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164:1998;93-100.
30. Urban J.L., Kumar V., Kono D.H., Gomez C., Horvath S.J., Clayton J., Ando D.G., Sercarz E.E., Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy [see comments]. Cell. 54:(4):1988;577-592.
31. Vanderlugt C.L., Begolka W.S., Neville K.L., Katz-Levy Y., Howard L.M., Eagar T.N., Bluestone J.A., Miller S.D. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol. Rev. 164:1998;63-72.
32. Yoshizawa I., Bronson R., Dorf M.E., Abromson-Leeman S. T-cell responses to myelin basic protein in normal and MBP-deficient mice. J. Neuroimmunol. 84:(2):1998;131-138.
33. Yu M., Kinkel R.P., Weinstock-Guttman B., Cook D.J., Tuohy V.K. HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum. Immunol. 59:(1):1998;15-24.